MYD88 and ovarian carcinoma: MyD88+ human ovarian carcinoma cells (SKOV3 and OVCAR3) and MyD88− ovarian carcinoma cell lines (A2780 and 3AO) were selected to investigate the TLR4 effects on apoptosis with Pac chemotherapy.